Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page
- CheckyesterdayChange DetectedA new revision tag v3.6.5 appears, replacing v3.6.4, indicating an updated revision in the page metadata.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new revision of the documentation.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision tag changed from v3.6.2 to v3.6.3. This indicates a new version of the study record, typically reflecting minor editorial or administrative updates rather than substantive changes to study data.SummaryDifference0.0%

- Check44 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, signaling a newer build of the study details page.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows that recruitment has ended for the study. It also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Interventions/Treatment heading formatting along with a new version label (Revision: v3.6.0).SummaryDifference0.4%

- Check65 days agoChange DetectedThe page's revision/version indicator was updated to v3.5.5, signaling a routine update to the site. This change is an internal version bump and does not alter the study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.